Aptahem AB (publ) (NGM: APTA)
Health Care · Biotechnology · SE
Skr—
— today · — 1Y
Aptahem AB (publ) (NGM: APTA) operates in the Biotechnology industry within the Health Care sector. The company is valued at $906.66K.
trading between 0.28 and 1.95.
Tweenvest scores Aptahem AB (publ) across four factors: quality 47/100, value 42/100. Its strongest factor is quality.
APTA price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $906.66K
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.23
- Dividend yield
- —
- Beta (5Y)
- 0.70
- 52-week high
- Skr1.95
- 52-week low
- Skr0.28
- Avg volume (3M)
- —
- Shares outstanding
- 25.93M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Bone Biologics CorporationNasdaqCM: BBLG | $1.09M | $0.40 | -15.44% |
| Valion Bio, Inc.NasdaqCM: VBIO | $1.04M | $1.17 | -45.33% |
| Halberd CorporationOTCPK: HALB | $941.60K | $0.00 | -3.08% |
| Exousia Bio, Inc.OTCPK: LMMY | $918.75K | $0.02 | +10.06% |
| BioXcel Therapeutics, Inc.OTCPK: BTAI.Q | $904.73K | $0.03 | -29.51% |
| Yubo International Biotech LimitedOTCPK: YBGJ | $886.19K | $— | — |
| Sunshine Biopharma, Inc.NasdaqCM: SBFM | $859.99K | $0.22 | -34.34% |
| Epigenomics AGDB: ECX | $858.33K | €0.87 | -1.14% |
Figures last refreshed Oct 18, 2026.